Upload
jonah-bentley
View
20
Download
0
Embed Size (px)
DESCRIPTION
ENOS Indian Investigator Meeting 13th March 2010 “The role of the Local Centre”. Sharon Ellender International Centre/Follow up Coordinator. The National Coordinator’s role/responsibilities. Promote trial Ensure necessary National Regulatory and Ethics approvals have been gained - PowerPoint PPT Presentation
Citation preview
www.enos.ac.uk/
ENOS Indian Investigator Meeting
13th March 2010 “The role of the Local Centre”
ENOS Indian Investigator Meeting
13th March 2010 “The role of the Local Centre”
Sharon Ellender International Centre/Follow up
Coordinator
www.enos.ac.uk/
The National Coordinator’s role/responsibilities The National Coordinator’s role/responsibilities Promote trial Ensure necessary National Regulatory and Ethics
approvals have been gained Recruit Local Centres Assist Local Centres with set up Organise translations if necessary Monitor Local Centres (at least 3 times) Perform 90 day patient follow-ups by telephone Ensure practice of NCC and Local Centres is
according to ICH/GCP standards ENOS Insurance cover
www.enos.ac.uk/
The local centre’s role /responsibilitiesThe local centre’s role /responsibilities
Obtain and maintain Local approvals Ensure adherence to GCP/ICH standards Ensure all staff are trained & remain trained Ensure that Site files are current Recruit patients 1-2 per month Complete all patient forms online within the
time line Fax paperwork to International Coordinating
Centre
www.enos.ac.uk/
What makes a good Local CentreWhat makes a good Local Centre
Commitment to trial (time, staff, hospital) Experience in doing stroke trials Commitment to recruit 1-2 patients per
month consistently IT access: PCs, Internet, Fax,communication Fax/record and complete data in a timely
manner Be prepared for monitor visits by the NCC or
ICC
www.enos.ac.uk/
Local centre monitoringLocal centre monitoring
Findings are measured against GCP-ICH Aim of visit is to assess:
Conduct of Local Centre Maintain Trial File Validity of data - check data against source data Evidence of consent,signed and dated Identify major and minor protocol deviations, and
other abnormal findings
www.enos.ac.uk/
Local centre monitoringLocal centre monitoring
NCC or ICC will perform the monitoring
Local Centres with poor monitoring reports will have further inspections and could be closed down
International Coordinating Centre (ICC) will monitor NCCs once during the trial period
Report is completed by monitor using template and sent to Principal Investigator, National Coordinator, and Chief Investigator
www.enos.ac.uk/
FindingsFindings
Document/Version Control Incorrect Version Numbers, e.g. consent forms
Times of stroke and consent Not written in medical records
Delegation of responsibilities Not defined
Trial File Non-existent, or not up to date
Dates and times Inconsistent between medical notes and trial data entered online and in the patient trial file
www.enos.ac.uk/
FindingsFindings
Poor recognition of antihypertensive agents Recognition of antihypertensives BP measurements Failure to take BP measurements at peak action of
patch (1-2 hours after placement of patch) Failure to take 2 BP measurements Failure to use OMRON machine Failure to obtain 7 days of BPs Failure to correctly record randomised treatment use on day
7 form Failure to record randomised treatment on the
drug chart
www.enos.ac.uk/
FindingsFindings
Equipment Broken printers,omrons, settings incorrect.
Local Centre staff training Staff not GCP trained
Includes Principal Investigator! Staff do not have GCP certificate All staff need an up to date CV (2 yearly)
NCC staff training Outcome assessor not mRS trained Outcome assessor does not have mRS certificate
www.enos.ac.uk/
Quality: Protocol ViolationsQuality: Protocol Violations
Protocol Violations are major deviations from the trial design
Must be reported to the DMC We must avoid them to maintain the trial’s
quality and to protect patients Sites should report them to the ICC and NCC
if they occurred accidentally May be discovered on the database or at a
site monitoring visit
www.enos.ac.uk/
Examples of Protocol ViolationsExamples of Protocol Violations
Patient under 18 years of age Randomisations >48 hours from onset of symptoms GCS <8 at randomisation No clinic weakness evident at any point Weakness present for <1 hour in total Limb weakness not present at time of enrolment Failure to obtain consent or assent of patient Systolic BP 140 - 220 mmHg at inclusion Dependent (mRS >2) prior to stroke Pre-existing antihypertensives not identified GTN patch not given during first 4 days (if
randomised)
www.enos.ac.uk/
Protocol ViolationsProtocol Violations
Patient pregnant or breastfeeding at inclusion Known severe concomitant illness Known non-stroke intracranial pathology,ie brain
tumour Patient already involved in another drug trial (or
within 3 months) at time of randomisation Planned use of antihypertensive agents when
randomised to ‘stop’, i.e. antihypertensives continued
No cranial imaging Failure to complete SAEs if they occur Follow up assessments are performed outside the
specified times
www.enos.ac.uk/
Quality: Protocol DeviationsQuality: Protocol Deviations
More minor deviations from trial protocol May occur due to unforeseen events or
mistakes. File notes can be used.
www.enos.ac.uk/
Examples of Protocol DeviationsExamples of Protocol Deviations
Patient does not receive GTN patch on days 5 to 7 of trial, if randomised to do so
Clinician unintentionally or intentionally (in an emergency situation) introduces new antihypertensives within first 7 days of trial, or recommences pre-trial antihypertensives if randomised not to do so
Patient does not receive usual antihypertensives if randomised to do so
There are not 3 OMRON blood pressure measurements at randomisation and 2 OMRON blood pressure measurements daily during first 7 days
Follow up assessments are submitted outside the specified time
Patient goes home <4 days after enrolment
www.enos.ac.uk/
SAE formsSAE forms
ADVERSE EVENTS Reported on the Day 7 Form only. SERIOUS ADVERSE EVENTS 1.Death
2.Life threatening events 3.Requires in patient hospitalization, prolonging of existing hospitalization 4.Results in persistent or significant disability /incapacity 5.Is a congenital anomaly/birth defect
Submit within 24 hours of the event Report SAE’S until completion of the day 90 follow up